This study aims to investigate the expression of miR-106b-5p in CKD and its regulatory relationship with the TGF-β/Smad pathway, providing new theoretical insights and potential therapeutic targets for CKD prevention and treatment. The gene discussed is TGFB1; the disease is chronic kidney disease.